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Abstract
BACKGROUND—Hypospadias is a common congenital malformation among men in which the 
urethral opening is ventrally displaced. Pesticide exposure has been suggested as a possible 
etiologic factor, but previous epidemiologic studies have produced inconsistent results.
METHODS—We used data from the National Birth Defects Prevention Study (NBDPS), a 
population-based case-control study, to examine maternal occupational exposure to fungicides, 
insecticides, and herbicides among 647 hypospadias case infants and 1496 unaffected male control 
infants with estimated delivery dates from October 1997 to December 2002. Periconceptional (1 
month before conception through the first trimester of pregnancy) pesticide exposures were 
assigned by an expert rater, assisted by a job-exposure matrix (JEM), from a job history completed 
by mothers during a telephone interview. Odds ratios (ORs) and 95% confidence intervals (CIs) 
were calculated with multivariable logistic regression, and adjusted for relevant covariates.
RESULTS—Maternal periconceptional occupational exposure to any pesticides (yes/no) was not 
associated with an increased risk of hypospadias (OR = 0.78; 95% CI = 0.61–1.01). Maternal 
occupational periconceptional pesticide exposure type (insecticides, fungicides, and herbicides) 
and estimated quantity also showed no significantly increased risk of hypospadias and no evidence 
of a dose-response relationship; however, the estimated pesticide exposure levels in this population 
were low.
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CONCLUSION—Using broad classes of insecticides, herbicides, and fungicides, we found no 
evidence that low intensity maternal periconceptional occupational pesticide exposure was a risk 
factor for hypospadias.
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INTRODUCTION
Hypospadias is a congenital malformation in which the meatus, the urethral opening, is 
displaced along the underside of the penis. Hypospadias is classified as first, second, or third 
degree depending on the position of the meatus. A third degree hypospadias is the most 
severe and difficult to correct. Overall, hypospadias occurs in 0.3 to 1% of male live births 
(Manson and Carr, 2003; Kurzrock and Karpman, 2004; Stokowski, 2004). Uncorrected 
hypospadias can cause difficulties in urination, abnormal sexual function, and adverse 
psychological consequences; for this reason, the majority of hypospadias must be surgically 
corrected (Bubanj et al., 2004; Mieusset and Soulie, 2005). Severe hypospadias may require 
several surgeries and still have an improper appearance and function (Miller and Grant, 
1997).
Because of their regulatory role in fetal genitourinary development, the disruption of 
endocrine hormones has been postulated to play a role in the development of hypospadias 
(Stoll et al., 1990; Akre et al., 1999; Moller and Weidner, 1999; Klip et al., 2002; Kurzrock 
and Karpman, 2004; Stokowski, 2004; Bianca et al., 2005; Carmichael et al., 2005; Palmer 
et al., 2005; Porter et al., 2005; Brouwers et al., 2006; Leung and Robson, 2007). Endocrine 
disrupting chemicals may have an estrogenic or androgen-antagonist effect (Sharpe and 
Skakkebaek, 1993; Baskin et al., 2001; Rittler and Castilla, 2002). Several common classes 
of pesticides have demonstrated potential to disrupt endocrine hormones in animal and in 
vitro studies (Steinhardt, 2004; Wang and Baskin, 2008) or to induce hypospadias in rats 
(Gray et al., 1999a; Gray et al., 1999b; Vilela et al., 2007).
Epidemiologic studies of pesticide exposure and hypospadias, however, have presented a 
conflicted picture. Few studies observed statistically significant changes in risk, with nearly 
equal numbers of studies having reported point estimates for reduced risks as increased 
risks. A meta-analysis of seven nonecologic studies on this topic noted a modest association 
between probable maternal pesticide exposure and hypospadias (pooled risk ratio = 1.36; 
95% confidence interval [CI], 1.04–1.77; Rocheleau et al., 2009). Five of those studies relied 
on farm work as a proxy for pesticide exposure; however, this type of work is associated 
with many other exposures, including solvents, fertilizers, and animal wastes. The remaining 
two studies utilized a job-exposure matrix (JEM), which is more cost-effective but less 
sensitive and specific than expert industrial hygienist review of detailed work histories 
(Tielemans et al., 1999; Teschke et al., 2002). Small sample sizes or limited availability of 
exposure data in most of these studies also restricted the evaluation of confounders and 
effect modifiers. To improve the study of maternal occupational pesticide exposure and risk 
Rocheleau et al. Page 2













of hypospadias, we used an industrial hygienist-guided JEM to assess workplace exposures 
of mothers in the National Birth Defects Prevention Study (NBDPS).
METHODS
Study Design
The NBDPS is a population-based case-control study of more than 30 different birth defects 
initially conducted by eight state-based surveillance systems (Arkansas, California, Iowa, 
Georgia, Massachusetts, New Jersey, New York, and Texas) and the Centers for Disease 
Control and Prevention. The details of the study design and methods have been described 
elsewhere (Yoon et al., 2001). Briefly, the NBDPS began in 1997 and is one of the largest 
case-control studies of birth defects in the United States. Affected children and fetuses were 
identified through active case ascertainment by each surveillance program. Controls were a 
random sample of all unaffected live births in the areas covered by the state-based birth 
defects surveillance systems for the NBDPS. Controls were identified from hospital delivery 
logs (Arkansas, California, Georgia [1997–2000], New York, and Texas) or birth certificate 
files (Georgia [2001–2002], Iowa, Massachusetts, and New Jersey).
Eligible cases were defined as having a diagnosis of a second-degree or third-degree 
hypospadias, with or without chordee (modified British Pediatric Association codes 
752.606, 752.607, 752.626, or 752.627). Abstracted medical records, including surgery 
reports where available, were reviewed at each study center by a clinical geneticist to 
identify potential cases. Records indicative of first-degree hypospadias (including coronal or 
glandular) were not collected, due to variable documentation in the medical records. Records 
of hypospadias without location information, epispadias, ambiguous genitalia with female 
karyotypes or without further description, and chordee alone were also not collected. All 
potential cases were reviewed by a second clinical geneticist (R.S.O.) to confirm that each 
case met eligibility and diagnosis criteria. Cases were further classified as isolated (no other 
major anomaly) or multiple (at least one major anomaly of another organ system, n = 34; 
Rasmussen et al., 2003). As hypospadias is specific to male infants, controls were also 
restricted to male infants.
Mothers of cases and controls were required to speak either English or Spanish and have 
access to a telephone. Computer-assisted telephone interviews were administered no sooner 
than 6 weeks and no later than 24 months after the estimated date of delivery (EDD; also 
referred to as ‘due date’) of the infant. The interview collected data on demographics, 
pregnancy characteristics, family history, medical and prenatal care, diet and lifestyle, and 
occupational history.
Study Variables
Subjects included in this analysis had an EDD (identified from abstracted medical records) 
from October 1, 1997 through December 31, 2002. During the interview, mothers were 
asked to provide information on all jobs worked for 1 month or more during the 3 months 
before pregnancy (B1–B3) through the end of the pregnancy (P1–P9 or EDD), including 
both full-time and part-time jobs and jobs worked at home, on a farm, or outside the home. 
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For each job, the mother provided the name of the employer, a job title, descriptions of what 
the employer produced or the service it provided, main job activities or duties, and 
chemicals or substances handled or machines used on the job. Each mother also provided the 
month and year she started and, if applicable, ended each job. Additionally, mothers reported 
the usual number of days worked per week and hours worked per day (Yoon et al., 2001). 
When subjects reported ending a job in the same month and year as beginning a different 
job, the 15th day of the month was considered the end date for the preceding job, with the 
latter job assumed to begin on the 16th day of the month. Otherwise, jobs were assigned as 
beginning on the first day of a reported month and ending on the last day of a reported 
month. Although mothers reported jobs held in the 3 months before pregnancy and 
throughout the entire pregnancy, the critical period of exposure is believed to be the 
periconceptional period. Jobs were considered relevant to this critical period if they occurred 
1 month before conception through the end of the first trimester (or termination of the 
pregnancy, if the pregnancy ended in <90 days from the date of conception).
Each job reported by the mother was assigned a North American Industry Classification 
System (U.S. Census Bureau, 2007) and 2000 Standard Occupational Classification (Bureau 
of Labor Statistics, 2000) code. A literature-based JEM (Samanic et al., 2008) was used to 
assign ‘typical’ pesticide exposures ratings to each job based on its 2000 Standard 
Occupational Classification and North American Industry Classification System (2007) 
codes; an industrial hygienist then used the job-specific information provided by the mother 
to modify these ratings. Exposure ratings estimated the probability (0, <1%, 1–33%, 34–
66%, 67–89%, or 90% or greater) of someone with that job description having exposure to 
the pesticide classes of insecticides, herbicides, and/or fungicides. Jobs considered possibly 
exposed to any class of pesticides (probability >0) were also assigned a score for probable 
exposure intensity (<1, 1–9, 10–99, or 100+ mg/hour) and frequency in a typical work week 
(<2, 2–9, 10–19, and 20+ hours per week) for that pesticide class. Confidence scores were 
also assigned for each job (very low, low, moderate, or high), reflecting the rater’s 
confidence in the accuracy of his/her ratings based on familiarity with the job process and 
the availability of industrial hygiene data. Hours per week was calculated based on self-
reported usual hours worked per day times the usual days per week worked. Observations 
exceeding 12 hours/day and 7 days/week were each reviewed for accuracy. When hours per 
day or days per week worked were unknown, an 8-hour day and/or a 5-day work week were 
assumed (<0.9% of jobs). Cumulative work exposure incorporated estimated exposure 
intensity, hours worked, and number of days worked during the critical period (B1–P3), and 
was calculated as:
(estimated exposure intensity in mg/hr)
× [(exposure frequency in hrs/week)/(40 hours/week)]
× [(hours worked/week)/7 (days/week)]
× (number of days worked in the exposure window) .
Family history, advancing maternal age, and intrauterine growth retardation have all been 
suggested as risk factors for hypospadias (Akre et al., 1999; Moller and Weidner, 1999; 
Kurzrock and Karpman, 2004; Bianca et al., 2005; Porter et al., 2005), and the disorder may 
have a multifactorial origin (Stoll et al., 1990; Stokowski, 2004). In utero exposure to the 
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synthetic estrogen diethylstilbestrol is a recognized risk factor for hypospadias (Klip et al., 
2002; Palmer et al., 2005; Brouwers et al., 2006), suggesting a possible role of estrogen in 
the etiology of hypospadias. Intake of synthetic estrogens and progestins, such as those used 
in oral contraceptives or assisted reproductive techniques, have also been associated with 
increased risk of hypospadias in some (but not all) studies (Carmichael et al., 2005; Leung 
and Robson, 2007). Based on these previously observed associations, we evaluated maternal 
age, parity, history of a miscarriage, singleton or multiple pregnancy, the gestational age and 
birth weight of the index infant, maternal alcohol consumption or cigarette smoking during 
the month before conception or any time during the first trimester of pregnancy, use of a 
folic acid-containing supplement, and maternal pre-pregnancy body mass index as potential 
covariates. Maternal and paternal race, income category, maternal and paternal highest 
education level attained, maternal and paternal birthplace outside the United States, 
language of the interview, and study center were also assessed. Because the study center 
reflects geography, and could relate to the types of agricultural products and chemicals used, 
interaction terms for the study center and pesticide type were assessed in logistic regression 
models. Use of progesterone or progestin-containing drugs has been suggested as a risk 
factor for hypospadias in a previous analysis of these data (Carmichael et al., 2005). All 
medications taken by month before pregnancy through the first trimester of pregnancy, for 
any indication, were classified as to whether or not they contained progesterone/progestins 
(yes/no). Because progestins used in contraceptives are typically of lower dose than those 
used for other indications, progestins were further categorized as being taken for 
contraception versus any other indication. A reported family history of hypospadias in a 
first-degree relative (father or full brother) was also examined.
Subjects with missing exposure or outcome data were excluded from all analyses. In the 
main analysis, subjects were limited to those with complete data for all included 
confounders and effect modifiers. To assess the impact of item nonresponse, a secondary 
analysis was also conducted in which a ‘missing’ category was created for all categorical 
confounding/effect modifying covariates with more than 10 missing responses (Miettinen, 
1985). No continuous variables considered for inclusion in the models had more than 10 
missing responses, thus imputation of missing continuous values was not performed.
It is unclear whether progesterone itself or the reason for taking progesterone might be the 
true risk factor. Progesterone and its synthetic analogues are primarily taken to prevent 
conception, to improve fertility, or to prevent pregnancy complications; the latter two 
indications (Carmichael et al., 2005) could be a consequence of a shared endocrine 
disrupting event that also led to development of hypospadias. As such, adjusting for the 
indication is inappropriate and would cause an attenuation of the observed effect. A 
subanalysis was conducted to examine the effects of separately adjusting for use of 
progestins and indication variables. Indication variables were the use of any fertility 
medication or procedure by either parent (yes/no), maternal use of any medication to prevent 
pregnancy complications (yes/no), or maternal use of oral or injected contraceptives (yes/
no).
Birthweight has been previously associated with hypospadias, although it is unclear if the 
relationship is due to a true etiologic relationship or whether both are shared consequences 
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of a separate risk factor. In the former condition, birthweight is an appropriate confounder to 
adjust for; in the latter condition, adjusting for birthweight would be inappropriate. 
Consequently, we did not adjust for birthweight in the main analysis but conducted a 
secondary analysis in which we adjusted for birthweight.
Some characteristics of mothers (e.g., maternal race/ethnicity or education level) tend to be 
highly correlated with the same characteristics of fathers (e.g., paternal race/ethnicity or 
education level); inclusion of both parents’ terms may be unnecessary or introduce 
collinearity. When there was little difference between use of the maternal or paternal 
characteristic in the models, we chose to use maternal characteristics for consistency.
Statistical Analysis
All analyses were conducted using SAS 9.1.3 (SAS, Cary, NC). Crude odds ratios (ORs) and 
95% CIs were calculated to determine the association between periconceptional maternal 
occupational pesticide exposure and hypospadias. Pesticide exposure was first evaluated as a 
bivariate variable (any pesticide exposure vs. none), then by pesticide exposure type (none; 
insecticides only; both herbicides and insecticides; both fungicides and insecticides; 
combined exposure to fungicides, herbicides, and insecticides); due to extensive overlap 
with insecticide exposure, it was not possible to evaluate fungicide and herbicide exposure 
separately. Finally, the cumulative exposure estimate (in total milligrams) to fungicides, 
insecticides, and herbicides, and total pesticides during the period of B1 to P3 was evaluated 
as both a continuous (linear, log-linear, quadratic) and categorical (quartiles among the 
exposed vs. no exposure; ≥90th percentile of exposure, <90th percentile of exposure, no 
exposure) variable.
To identify potential confounding variables, we used the chi-square test for categorical 
variables and linear regression for continuous variables. Variables that were related to both 
hypospadias and pesticide exposure terms (α ≤ 0.10) or that changed the OR estimate for 
the main effects (≥10%) were included in multivariable model selection. We evaluated 
biologically plausible interaction terms in the multivariable models; interaction terms whose 
inclusion changed the OR for the main effects (≥10%) were considered in the model 
selection process. A researcher-guided stepwise selection scheme was used to identify the 
most parsimonious model that adequately fit the data.
RESULTS
Comparison of Cases and Controls
Approximately 70% of eligible mothers participated in the NBDPS (cases, 71.6%; controls, 
69.1%). Interview data were available on 1171 infants affected with hypospadias and 2980 
unaffected male infants. Mothers who did not work any job in the month before pregnancy 
or at any time during the first trimester of pregnancy, or who could not be assigned 
occupational exposure due to missing or incomplete job information, were excluded (n = 
2012). Birth mothers of 646 cases and 1493 controls that completed the NBDPS interview 
were evaluated in this study. As shown in Table 1, case mothers were more likely than 
control mothers to be older, have a higher household income, and be primiparous. Both 
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fathers and mothers of case infants were more likely to have completed college, and less 
likely to be of Hispanic ethnicity. Preterm birth, low birth weight, and multiple gestations 
were more common among case infants than control infants. The proportion of cases also 
varied by study center.
Main Analysis
The main analysis excluded all subjects with a first-degree family history of hypospadias (n 
= 30) and multiple gestations (n = 105) or both family history and multiple gestations (n = 
2). Most subjects who were estimated to be exposed to pesticides were either exposed only 
to insecticides or to all three types of pesticides (insecticides, herbicides, and fungicides; 
Table 2). Jobs held by mothers were very diverse. Farmers/agricultural laborers accounted 
for a large portion of jobs with high intensity exposure to fungicides, herbicides, and/or 
insecticides. Property managers/landlords also comprised a large portion of workers with 
low to moderate intensity (but infrequent) exposure to herbicides and insecticides. Teachers, 
child care workers, health care workers, and restaurant servers were the largest group of 
workers considered to have very low intensity insecticide exposure. Examples of jobs with 
very low intensity herbicide exposures include sales staff in garden and lawn supply centers 
and janitors. Among jobs rated as having very low fungicide exposure intensity, work in 
grocery stores and food preparation/food service were the most common.
Any maternal occupational pesticide exposure (yes/no) during the month before conception 
and during the first trimester of pregnancy suggested a reduced risk in the crude analysis 
(OR = 0.71; 95% CI = 0.57–0.88; Table 3). Adjusting for center, maternal race, maternal 
age, infant gestational age, and parity caused little change in the observed relationship 
between hypospadias and any maternal occupational pesticide exposure (adjusted OR = 
0.78; 95% CI = 0.61–1.01).
Cumulative maternal occupational exposure to fungicides, insecticides, and herbicides 
during the periconceptional period was not associated with hypospadias, both before and 
after adjustment for center, maternal race, maternal age, gestational age of the infant, and 
parity (Table 3). There was no evidence of a dose-response effect among quartiles of 
estimated exposure. Restricting the analysis to third-degree (more severe) hypospadias did 
not cause a consistent increase or decrease in the observed ORs across categories of 
exposure to insecticides, herbicides, fungicides, or total pesticides (Table 3).
Secondary Analyses
Including subjects with a family history of hypospadias and multiple gestations resulted in 
some alterations in the point estimates and CIs, but no changes in the interpretation of the 
ORs (data not shown). Neither excluding subjects with a very low confidence score, 
excluding potentially exposed subjects with low exposure probability (<67%), nor excluding 
hypospadias cases with other birth defects caused >10% change in the ORs or CIs (data not 
shown). We could not stratify by peak exposure intensity because very few mothers had high 
intensity exposures. There was no evidence of a threshold effect comparing those at the 90th 
percentile of estimated exposure to unexposed subjects (data not shown).
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Substantial item nonresponse was noted for family income (9.8% missing) and use of 
medications to prevent pregnancy complications (23.0%, although all medication use was 
solicited in the interview, regardless of indication). In a secondary analysis, using a 
‘missing’ category for these and any other variables with >10 missing responses (vs. 
restricting the analysis to subjects with complete response for all covariates in the model) 
altered the ORs slightly, but all CIs remained wide.
Because of the endocrine-disrupting potential of pesticides, confounding or interaction due 
to the use of progestin-containing drugs was a major concern. Previous work has shown an 
association between use of progestin-containing drugs and hypospadias, although it has been 
less clear whether the true risk factor was the medication or the indication for using the 
medication. Neither adjustment for the active medication ingredient (any progesterone/
progestin [yes/no]) nor indication for medication use (fertility treatments or procedures by 
either parent [yes/no]; use of medications to prevent pregnancy complications [yes/no]; and 
use of any contraceptive [yes/no]) substantially altered the ORs for pesticide exposure and 
hypospadias risk.
DISCUSSION
Overall, we observed either no association or a decreased association between second-
degree or third-degree hypospadias and maternal occupational exposure to pesticides during 
the month before conception through the first trimester of pregnancy. Point estimates less 
than unity may be the result of uncontrolled confounding (e.g., the ‘healthy farmer effect’) 
or because our study measured the prevalence of hypospadias at birth, rather than the true 
incidence of hypospadias. Previous studies have suggested an association between fetal 
exposure to pesticides and an increase in fetal death (Arbuckle and Sever, 1998; Settimi et 
al., 2008). Incident hypospadias occurring among fetuses that were spontaneously aborted 
would not be observed in this study because we were only able to observe prevalent 
hypospadias at birth.
Although some point estimates were elevated, none were statistically significant; these 
results may be spurious due to multiple comparisons. There was no evidence of a dose-
response relationship across quartiles of estimated exposure to any pesticide, insecticides, 
herbicides, or fungicides; nor did we see a threshold effect in the main analysis, although our 
estimates were imprecise as shown by the wide CIs. When we restricted our analysis to 
controls and more severe cases (third-degree hypospadias) we did not observe any consistent 
increase or decrease within quartiles of estimated exposure to any pesticide, insecticides, or 
herbicides.
The estimated cumulative periconceptional pesticide exposure levels among study 
participants were generally quite low; these results may not be applicable to higher pesticide 
levels. To reduce potential exposure misclassification, we conducted two separate analyses 
in which we excluded subjects (1) for whom the expert raters’ had low confidence of 
exposure assessment, and (2) whose jobs might have been exposed, although with low 
(<67%) probability. Neither analysis revealed any significantly increased association 
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between maternal occupational pesticide exposure and hypospadias, although these 
comparisons were imprecise.
Our finding of no increased risk of hypospadias associated with maternal pesticide exposure 
is consistent with two previous studies using a JEM to assign maternal pesticide exposure 
(Pierik et al., 2004; Carbone et al., 2007); to our knowledge, however, this is the first study 
to evaluate maternal occupational pesticide exposure based on a JEM, modified as needed by 
an expert rater, in a population-based setting. Exposure assessments performed by industrial 
hygienists are thought to be more accurate than self-reported exposure or assigning exposure 
based on job title alone (McGuire et al., 1998). We used a rater with broad industry 
experience and expertise in coding retrospective exposure histories, combining rater 
expertise with a data-driven JEM.
Previous studies of the potential association between pesticide exposure and hypospadias 
have faced several methodological limitations, including small sample sizes or very limited 
data due to the use of existing records. Five of seven studies evaluated in a recent meta-
analysis (Rocheleau et al., 2009) relied on farm work as a proxy for pesticide exposure. The 
remaining two studies utilized a JEM. Small sample sizes or limited availability of exposure 
data in most of these studies also restricted the evaluation of confounders and effect 
modifiers. Our data-set provided a relatively large sample size and detailed information, 
which allowed us to adjust for relevant factors such as parity and maternal age.
In our bivariate analysis, we observed several positive associations with hypospadias that 
have been identified elsewhere: advancing maternal age (Porter et al., 2005), low parity 
(Weidner et al., 1999; Aschim et al., 2004; Morera et al., 2006), low birth weight (Weidner 
et al., 1999; Aschim et al., 2004; Morera et al., 2006), multiple gestation (Weidner et al., 
1999), family history of hypospadias (Weidner et al., 1999; Aschim et al., 2004; Morera et 
al., 2006), and parental subfertility (Fritz and Czeizel, 1996; Swan et al., 2003; Swan, 2006; 
Asklund et al., 2007; Roeleveld and Bretveld, 2008). Hispanic ethnicity was also associated 
with reduced risk of hypospadias in our analysis, as previously described in the literature 
(Kirby et al., 2000). This consistency with other research in describing these associations 
supports our overall findings.
Our study benefited from the systematic collection of interview and outcome data. In 
particular, the NBDPS used a computer-assisted telephone interview with preprogrammed 
probes to elicit detailed responses from subjects in a systemized manner. These steps may 
reduce variations in data quality (Clavel and Hemon, 1993; Stewart and Stewart, 1995). 
Since creating a timeline may improve subjects’ recall (Bradburn et al., 1987), a pregnancy 
calendar was created for all NBDPS participants at the beginning of their interview.
Despite the strengths of this study, these data must be interpreted cautiously. Most pesticide-
exposed women in the population were only exposed to very low estimated pesticide levels. 
The lack of an association between pesticides and hypospadias at the low levels observed in 
our study does not indicate the lack of a relationship between higher maternal doses of 
pesticides and hypospadias. Also, due to inconsistency with animal data at a range of 
exposure levels, we must consider that our negative findings may reflect exposure 
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misclassification rather than a lack of association between maternal pesticide exposure and 
hypospadias. Animal studies indicate that maternal exposure to certain pesticides at critical 
periods in urogenital development can induce hypospadias, possibly through an endocrine 
disruption mechanism (Gray et al., 1999a; Gray et al., 1999b; Gray et al., 2001; Kang et al., 
2004). Hypospadias occurs when fusion of the urogenital urethral folds, primarily occurring 
between weeks 8 and 14 of gestation in humans, is interrupted; the fusion process is largely 
controlled by endocrine hormones produced by the fetal testes (Baskin et al., 2001; 
Kurzrock and Karpman, 2004). Exposure to other endocrine-disrupting chemicals, such as 
progestins (Calzolari et al., 1986; Carmichael et al., 2005) and diethylstilbestrol (Klip et al., 
2002; Brouwers et al., 2006), are also associated with hypospadias.
Although expert assessments have been shown to be more accurate than self-reports or JEMs 
alone, they are still subject to exposure misclassification (Kauppinen, 1994; Mannetje et al., 
2003); such misclassification of exposure will generally bias results toward the null 
(Kromhout et al., 1987; Benke et al., 1997; Blair et al., 2007). A case-control study design, 
although efficient for rare outcomes like hypospadias, generally precludes the collection of 
more accurate direct monitoring data. We were also unable to account for exposure 
modifiers such as the use of personal protective equipment, hygiene, ventilation during 
exposed tasks, or changes in job tasks during pregnancy. Because data were based on recall, 
we were also not able to examine specific pesticides or functional classes of pesticides. The 
broad categories of fungicides, insecticides, and herbicides each contain a diverse array of 
chemicals that are unlikely to all exhibit similar properties. Less specific measures of 
exposure generally dilute any observed associations (Friesen et al., 2007), as they tend to 
mix effects.
Even if maternal occupational exposure were perfectly measured, other sources of pesticide 
exposure may not be adequately accounted for. Mothers can be exposed to pesticides 
through pesticide drift or community-wide sprayings, through residential applications of 
pesticides in and around the home, through carry home exposures from other household 
members who may be exposed to pesticides, and from pesticide residues on food. We were 
only able to collect self-reports of another household member working with pesticides, but 
proxy reports of occupational exposures are not usually accurate (Johnson et al., 1993; 
Fryzek et al., 2000; Campbell et al., 2007). Paternal occupational exposure may also be 
linked to hypospadias risk by exerting effects during spermatogenesis. We were unable to 
account for paternal pesticide exposure in our study; this prevents us from examining 
paternally mediated risk through sperm damage or carry home exposures. Future work can 
attempt to reduce exposure misclassification by measuring all sources of potential pesticide 
exposure – occupational and residential, of both parents.
Future work is also needed to examine the relationship between first-degree hypospadias and 
periconceptional pesticide exposure. Our study was limited to second-degree and third-
degree hypospadias; different forms of hypospadias might have different etiologies. We were 
also unable to examine interactions with genetic factors, such as those that influence 
pesticide metabolism. Future work should also examine gene and environment interactions.
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Finally, although previous work has identified an increased risk of hypospadias in the sons 
of women who work in agriculture (Rocheleau et al., 2009), agricultural workers experience 
a number of unique exposures that are not limited to pesticides; these include fertilizers, 
diesel fuel, animal wastes, solvents, and hormones. Hormones are often mixed with livestock 
feed to promote growth, enhance milk or egg production, or influence the development of 
lean muscle mass. An association between maternal agricultural work and hypospadias 
could be due to agricultural exposures other than pesticides. In our study, few women 
worked in agriculture; we were not able to stratify pesticide exposure by agricultural versus 
nonagricultural work. Given that endocrine disruption is believed to play a causal role in the 
development of hypospadias, potential hormone exposures among agricultural workers 
deserves further study. Also, agricultural workers tend to have greater pesticide exposures 
than the generally low exposed population in our study.
In conclusion, this study found no consistent association between estimated low-dose 
maternal occupational pesticide exposure and hypospadias. This study was not able to 
address the health effects of higher doses of pesticide exposure, the potential contribution of 
paternal pesticide exposure to hypospadias risk, the effects of nonoccupational pesticide 
exposures, the effects of specific pesticides, or the effect of other agricultural exposures 
(such as hormones). We also could not assess the likelihood or magnitude of potential 
exposure misclassification. Future studies should focus on improving study designs to 
address these shortcomings.
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Table 1
Demographic Characteristics of Hypospadias Case and Control Families, NBDPS 1997 to 2002
Hypospadias Controls
n (%)a n (%)a
n = 646 n = 1493
Maternal characteristics Age at conceptionb
 Less than 20 years old 28 (4.3) 129 (8.6)
 20–24 years old 109 (16.9) 323 (21.6)
 25–29 years old 148 (22.9) 403 (27.0)
 30–34 years old 228 (35.3) 413 (27.7)
 More than 35 years old 133 (20.6) 225 (15.1)
Education levelb
 Did not complete high school 39 (6.0) 144 (9.6)
 Completed high school 309 (47.8) 837 (56.1)
 Completed college or higher 298 (46.1) 509 (34.1)
 Missing 0 (0.0) 3 (0.2)
Race and ethnicityb
 White, non-Hispanic 461 (71.4) 985 (66.0)
 Black, non-Hispanic 93 (14.4) 178 (11.9)
 Hispanic 54 (8.4) 245 (16.4)
 Other 34 (5.3) 82 (5.5)
 Missing 4 (0.6) 3 (0.2)
Household incomeb
 Less than $10,000 annually 45 (7.0) 178 (11.9)
 $10,000–$29,999 annually 122 (18.9) 357 (23.9)
 $30,000–$49,999 annually 108 (16.7) 255 (17.1)
 $50,000 or more annually 332 (51.4) 532 (35.6)
 Missing 39 (6.0) 171 (11.5)
Pre-pregnancy BMI
 <18.5 (under weight) 29 (4.5) 82 (5.5)
 18.5–24.9 (normal weight) 350 (54.2) 839 (56.2)
 25.0–29.9 (over weight) 149 (23.1) 341 (22.8)
 ≥30 (obese) 109 (16.9) 202 (13.5)
 Missing 9 (1.4) 29 (1.9)
Smoked cigarettes during periconceptional period
 Yes 122 (18.9) 324 (21.7)
 No 524 (81.1) 1169 (78.3)
Drank alcohol during periconceptional period
 Yes 304 (47.1) 667 (44.7)
 No 337 (52.2) 818 (54.8)
 Missing 5 (0.8) 8 (0.5)
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Hypospadias Controls
n (%)a n (%)a
n = 646 n = 1493
Used folic acid supplements during periconceptional period
 Yes 396 (61.3) 776 (60.0)
 No 250 (38.7) 717 (40.0)
Parousb
 Yes 264 (40.9) 838 (56.1)
 No 382 (59.1) 654 (43.8)
 Missing 0 (0.0) 1 (0.1)
Used progesterone/progestin during periconceptional period
 Yes 100 (15.5) 181 (12.1)
 No 546 (84.5) 1312 (87.9)
Household member worked with pesticidesc
 Yes 6 (0.9) 31 (2.1)
 No 636 (98.5) 1458 (97.7)
 Missing/unknown 4 (0.6) 3 (0.2)
Paternal characteristics Education leveld
 Did not complete high school 234 (36.2) 649 (43.5)
 Completed high school 134 (20.7) 321 (21.5)
 Completed college or higher 259 (40.1) 493 (33.0)
 Missing 19 (2.9) 30 (2.0)
Race and ethnicityb
 White, non-Hispanic 372 (57.6) 899 (60.2)
 Black, non-Hispanic 91 (14.1) 174 (11.7)
 Hispanic 45 (7.0) 205 (13.7)
 Other 41 (6.3) 94 (6.3)
 Missing 97 (15.0) 121 (8.1)
Infant characteristics Gestational ageb
 Very preterm (<32 weeks) 55 (8.5) 23 (1.5)
 Preterm (32–36 weeks) 125 (19.3) 106 (7.1)
 Term (37–45 weeks) 466 (72.1) 1364 (91.4)
Birth weightb
 <2500 g 175 (27.1) 89 (6.0)
 ≥2500 g 465 (72.0) 1395 (93.4)
 Missing 6 (0.9) 9 (0.6)
Pluralityb
 Singleton 588 (91.0) 1444 (96.7)
 Two or more 56 (8.7) 47 (3.1)
 Missing 2 (0.3) 2 (0.1)
Conceived during/after fertility treatments or proceduresb
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Hypospadias Controls
n (%)a n (%)a
n = 646 n = 1493
 Yes 81 (12.5) 77 (5.2)
 No 565 (87.5) 1415 (94.8)
 Missing 0 (0.0) 1 (0.1)
First-degree relative with hypospadiasb
 Yes 30 (4.6) 2 (0.1)
 No 616 (95.4) 1491 (99.9)
Study centerb
 Arkansas 74 (11.5) 183 (12.3)
 California 23 (3.6) 172 (11.5)
 Georgia 115 (17.8) 188 (12.6)
 Iowa 18 (2.8) 220 (14.7)
 Massachusetts 108 (16.7) 220 (14.7)
 New Jersey 237 (36.7) 185 (12.4)
 New York 54 (8.4) 181 (12.1)
 Texas 17 (2.6) 144 (9.7)
a
Percentages may not total 100 because of rounding.
b
p value < 0.0001.
c
p value < 0.05.
d
p value < 0.001.
NBDPS, National Birth Defects Prevention Study; BMI, body mass index.
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Table 2
Reported Patterns of Estimated Periconceptional Exposure to Pesticides among Case and Control Mothers, 
NBDPS 1997 to 2002
Hypospadias Controls
na (%) na (%)
Total pesticide exposureb
 Any 140 (25.0) 464 (32.2)
 None 419 (75.0) 979 (67.8)
Pesticide exposure, by class
 None 419 (75.0) 979 (67.8)
 Insecticides only 102 (18.2) 318 (22.0)
 Herbicides only 0 (0.0) 2 (0.1)
 Fungicides only 0 (0.0) 0 (0.0)
 Both insecticides and herbicides 9 (1.6) 28 (1.9)
 Both insecticides and fungicides 2 (0.4) 4 (0.3)
 Both herbicides and fungicides 0 (0.0) 0 (0.0)
 Insecticides, herbicides, and fungicides 27 (4.8) 112 (7.8)
a
Subjects restricted to singleton births without a reported first-degree family history of hypospadias.
b
p value < 0.0001.
NBDPS, National Birth Defects Prevention Study.
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